{"entity":{"type":"insider","cik":"0001630998","url":"/insider/0001630998","json_url":"/insider/0001630998.json","name":"Gibertini Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":8,"first":"2015-05-11","last":"2016-06-07","span_basis":"filed_date"},"name_variants":[{"name":"Gibertini Michael","source":"filing","n_filings":8,"first_seen":"2015-05-11","last_seen":"2016-06-07"}],"transactions":[{"id":3341135,"accession":"0001630998-16-000011","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001630998-16-000011","line_url":"/filing/0001630998-16-000011","is_derivative":false,"issuer_cik":"0001610950","issuer_name":"INC Research Holdings, Inc.","issuer_ticker":"INCR","issuer_name_source":null,"issuer_url":"/issuer/0001610950","owner_cik":"0001630998","owner_name":"Gibertini Michael","owner_display_name":"Gibertini Michael","owner_url":"/insider/0001630998","role":"Officer (President Clinical Development)","role_mark":"O","role_mark_label":"Officer (President Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Clinical Development","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":213966.0,"shares_display":"213,966","price_per_share":43.1057806833796,"price_display":"43.11","price_state":"stated","total_value":9223171.4697,"total_display":"9,223,171.47","total_whole":"9,223,171","shares_owned_after":56316.0,"shares_owned_after_display":"56,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-07","scope":"insider","n_lines":8},{"id":2411233,"accession":"0001630998-16-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001630998-16-000010","line_url":"/filing/0001630998-16-000010#line-2","is_derivative":false,"issuer_cik":"0001610950","issuer_name":"INC Research Holdings, Inc.","issuer_ticker":"INCR","issuer_name_source":null,"issuer_url":"/issuer/0001610950","owner_cik":"0001630998","owner_name":"Gibertini Michael","owner_display_name":"Gibertini Michael","owner_url":"/insider/0001630998","role":"Officer (President Clinical Development)","role_mark":"O","role_mark_label":"Officer (President Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Clinical Development","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":40.782,"price_display":"40.78","price_state":"stated","total_value":367038.0,"total_display":"367,038.00","total_whole":"367,038","shares_owned_after":47282.0,"shares_owned_after_display":"47,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-01","filed_date":"2016-04-04","scope":"insider"},{"id":2619035,"accession":"0001630998-16-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001630998-16-000009","line_url":"/filing/0001630998-16-000009#line-2","is_derivative":false,"issuer_cik":"0001610950","issuer_name":"INC Research Holdings, Inc.","issuer_ticker":"INCR","issuer_name_source":null,"issuer_url":"/issuer/0001610950","owner_cik":"0001630998","owner_name":"Gibertini Michael","owner_display_name":"Gibertini Michael","owner_url":"/insider/0001630998","role":"Officer (President Clinical Development)","role_mark":"O","role_mark_label":"Officer (President Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Clinical Development","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":39.853,"price_display":"39.85","price_state":"stated","total_value":358677.0,"total_display":"358,677.00","total_whole":"358,677","shares_owned_after":47282.0,"shares_owned_after_display":"47,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-02","scope":"insider"},{"id":3017372,"accession":"0001630998-16-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001630998-16-000008","line_url":"/filing/0001630998-16-000008","is_derivative":false,"issuer_cik":"0001610950","issuer_name":"INC Research Holdings, Inc.","issuer_ticker":"INCR","issuer_name_source":null,"issuer_url":"/issuer/0001610950","owner_cik":"0001630998","owner_name":"Gibertini Michael","owner_display_name":"Gibertini Michael","owner_url":"/insider/0001630998","role":"Officer (President Clinical Development)","role_mark":"O","role_mark_label":"Officer (President Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Clinical Development","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":40.57244444444444,"price_display":"40.57","price_state":"stated","total_value":365152.0,"total_display":"365,152.00","total_whole":"365,152","shares_owned_after":48282.0,"shares_owned_after_display":"48,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-01","filed_date":"2016-02-02","scope":"insider","n_lines":2},{"id":2878374,"accession":"0001630998-16-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001630998-16-000006","line_url":"/filing/0001630998-16-000006","is_derivative":false,"issuer_cik":"0001610950","issuer_name":"INC Research Holdings, Inc.","issuer_ticker":"INCR","issuer_name_source":null,"issuer_url":"/issuer/0001610950","owner_cik":"0001630998","owner_name":"Gibertini Michael","owner_display_name":"Gibertini Michael","owner_url":"/insider/0001630998","role":"Officer (President Clinical Development)","role_mark":"O","role_mark_label":"Officer (President Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Clinical Development","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":46.8326,"price_display":"46.83","price_state":"stated","total_value":421493.4,"total_display":"421,493.40","total_whole":"421,493","shares_owned_after":39382.0,"shares_owned_after_display":"39,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider","n_lines":2},{"id":8588510,"accession":"0001630998-15-000005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001630998-15-000005","line_url":"/filing/0001630998-15-000005","is_derivative":false,"issuer_cik":"0001610950","issuer_name":"INC Research Holdings, Inc.","issuer_ticker":"INCR","issuer_name_source":null,"issuer_url":"/issuer/0001610950","owner_cik":"0001630998","owner_name":"Gibertini Michael","owner_display_name":"Gibertini Michael","owner_url":"/insider/0001630998","role":"Officer (President Clinical Development)","role_mark":"O","role_mark_label":"Officer (President Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Clinical Development","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":46.51799666666667,"price_display":"46.52","price_state":"stated","total_value":418661.97,"total_display":"418,661.97","total_whole":"418,662","shares_owned_after":37667.0,"shares_owned_after_display":"37,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider","n_lines":3},{"id":8706437,"accession":"0001630998-15-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001630998-15-000004","line_url":"/filing/0001630998-15-000004#line-2","is_derivative":false,"issuer_cik":"0001610950","issuer_name":"INC Research Holdings, Inc.","issuer_ticker":"INCR","issuer_name_source":null,"issuer_url":"/issuer/0001610950","owner_cik":"0001630998","owner_name":"Gibertini Michael","owner_display_name":"Gibertini Michael","owner_url":"/insider/0001630998","role":"Officer (President Clinical Development)","role_mark":"O","role_mark_label":"Officer (President Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Clinical Development","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":41.7,"price_display":"41.70","price_state":"stated","total_value":375300.0,"total_display":"375,300.00","total_whole":"375,300","shares_owned_after":36282.0,"shares_owned_after_display":"36,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-03","scope":"insider"},{"id":8910900,"accession":"0001630998-15-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001630998-15-000002","line_url":"/filing/0001630998-15-000002#line-1","is_derivative":false,"issuer_cik":"0001610950","issuer_name":"INC Research Holdings, Inc.","issuer_ticker":"INCR","issuer_name_source":null,"issuer_url":"/issuer/0001610950","owner_cik":"0001630998","owner_name":"Gibertini Michael","owner_display_name":"Gibertini Michael","owner_url":"/insider/0001630998","role":"Officer (President Clinical Development)","role_mark":"O","role_mark_label":"Officer (President Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Clinical Development","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":29.68,"price_display":"29.68","price_state":"stated","total_value":1484000.0,"total_display":"1,484,000.00","total_whole":"1,484,000","shares_owned_after":27870.0,"shares_owned_after_display":"27,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-07","filed_date":"2015-05-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001610950","name":"INC Research Holdings, Inc.","url":"/issuer/0001610950","role":"Officer (President Clinical Development)","n_filings":8,"first_seen":"2015-05-11","last_seen":"2016-06-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001630998","retrieved_at":"2026-08-25T10:58:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}